The BBB is an ultra-tight layer of cells lining the brain's blood vessels. Think of it like a super-filter or a nightclub with an extremely strict bouncer. It lets nutrients and oxygen through but blocks almost everything else, including most drugs. It exists to protect the brain from toxins and infections.
Why it matters for MHS treatments: Any drug that targets microglia (brain immune cells) or neurons must cross the BBB. Most drugs in development never get a chance to do this because they can't penetrate the barrier. AL-605 was specifically engineered (via structure-guided drug design) to cross the BBB. It's like the drug was given "VIP access" to the brain club. This is a genuine engineering breakthrough, not a minor tweak.